Literature DB >> 1487615

Liver damage in Italian patients with hereditary hemochromatosis is highly influenced by hepatitis B and C virus infection.

A Piperno1, S Fargion, R D'Alba, L Roffi, A L Fracanzani, L Vecchi, M Failla, G Fiorelli.   

Abstract

We evaluated the prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection in 78 Italian patients with hereditary hemochromatosis as well as the relation between HCV antibody (anti-HCV) status, hepatitis B surface antigen (HBsAg) and liver histology. None of the patients had been transfused or ever consumed more than 60 g of alcohol per day. Eighteen showed histological signs of chronic hepatitis, active cirrhosis was present in 12, chronic active hepatitis in 4 and chronic persistent hepatitis in 2. Liver fibrosis or cirrhosis without inflammatory activity was observed in 31 subjects, whereas liver histology was normal except for iron overload in 18. The prevalence of HBsAg in the whole series was 5% and of anti-HCV was 20.5%. The prevalence of HBsAg and anti-HCV was significantly higher in the chronic hepatitis group than in the fibrosis/cirrhosis (p = 0.01) and the normal groups (p < 0.01). Fourteen of 18 hereditary hemochromatosis patients with chronic hepatitis were HBsAg (4) or anti-HCV (10) positive and all the latter subgroup had HCV-RNA in their serum as shown by the polymerase chain reaction. Although most of the patients with associated chronic hepatitis had cirrhosis, their serum ferritin levels and amount of mobilizable iron were significantly lower than those of the fibrosis/cirrhosis group (p < 0.01). This indicates that hepatitis viral infection acts synergistically with iron in accelerating the development of liver damage.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1487615     DOI: 10.1016/s0168-8278(05)80671-3

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  11 in total

Review 1.  Histopathology and detection of hepatitis C virus in liver.

Authors:  P J Scheuer; K Krawczynski; A P Dhillon
Journal:  Springer Semin Immunopathol       Date:  1997

2.  Iron, HCV and the liver.

Authors:  K P Maier
Journal:  World J Gastroenterol       Date:  1997-06-15       Impact factor: 5.742

3.  Hepatic iron contents and response to interferon-alpha in patients with chronic hepatitis C. Relationship to genotypes of hepatitis C virus.

Authors:  N Izumi; N Enomoto; M Uchihara; T Murakami; K Ono; O Noguchi; S Miyake; T Nouchi; K Fujisawa; F Marumo; C Sato
Journal:  Dig Dis Sci       Date:  1996-05       Impact factor: 3.199

4.  Chronic iron overload in rats induces oval cells in the liver.

Authors:  P G Smith; G C Yeoh
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

5.  Hemochromatosis gene mutations: prevalence and effects on pegylated-interferon and ribavirin therapy response in chronic hepatitis C in sardinia.

Authors:  Margherita Sini; Orazio Sorbello; Alberto Civolani; Luigi Demelia
Journal:  J Clin Exp Hepatol       Date:  2012-09-21

Review 6.  Role of iron in hepatic fibrosis: one piece in the puzzle.

Authors:  Marie-A Philippe; Richard-G Ruddell; Grant-A Ramm
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

Review 7.  Hepatitis C: progress and problems.

Authors:  J A Cuthbert
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

Review 8.  HFE-related hemochromatosis: an update for the rheumatologist.

Authors:  Emma Husar-Memmer; Andreas Stadlmayr; Christian Datz; Jochen Zwerina
Journal:  Curr Rheumatol Rep       Date:  2014-01       Impact factor: 4.592

9.  Correlation between serum levels of alanine aminotransferase and ferritin in male blood donors with antibody to hepatitis C virus.

Authors:  T Takikawa; H Hayashi; N Nishimura; M Yano; T Isomura; N Sakamoto
Journal:  J Gastroenterol       Date:  1994-10       Impact factor: 7.527

10.  Hemochromatosis Gene Polymorphism as a Predictor of Sustained Virological Response to Antiviral Treatment in Egyptian Chronic Hepatitis C Patients.

Authors:  Mai I Mehrez; Dina Sa Fattah; Naglaa Aa Azeem; Mohamed A Saleh; Khadiga M Mostafa
Journal:  Euroasian J Hepatogastroenterol       Date:  2017-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.